Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2008-05-27
2008-05-27
Jiang, S. Anna (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C435S184000
Reexamination Certificate
active
07378398
ABSTRACT:
A method for treating an adenocarcinoma excluding colon cancer, lung cancer and gastric cancer, comprising administering to a subject in need thereof and suffering from adenocarcinoma cancer, a pharmaceutically effective amount of at least one sulfoquinovosylacylglycerol compound represented by formula (1):wherein R101represents an acyl residue of an unsaturated higher fatty acid, and R102represents a hydrogen atom, and/or at least one pharmaceutically acceptable salt thereof.
REFERENCES:
patent: 5489578 (1996-02-01), Rosen et al.
patent: 5695752 (1997-12-01), Rosen et al.
patent: 5783693 (1998-07-01), Bertozzi et al.
patent: 6395886 (2002-05-01), Yamazaki et al.
patent: 6444795 (2002-09-01), Yamazaki et al.
patent: 6518248 (2003-02-01), Yamazaki et al.
patent: 6518410 (2003-02-01), Yamazaki et al.
patent: 6770629 (2004-08-01), Yamazaki et al.
patent: 7148200 (2006-12-01), Yamazaki et al.
patent: 2002/0022597 (2002-02-01), Yamazaki et al.
patent: 2002/0028776 (2002-03-01), Yamazaki et al.
patent: 2002/0028777 (2002-03-01), Yamazaki et al.
patent: 2002/0052327 (2002-05-01), Yamazaki et al.
patent: 2002/0173471 (2002-11-01), Yamazaki et al.
patent: 55-130996 (1980-10-01), None
patent: 03-052815 (1991-03-01), None
patent: 03-052816 (1991-03-01), None
patent: 03-066603 (1991-03-01), None
patent: 60-040159 (1991-09-01), None
patent: 03-246203 (1991-11-01), None
patent: 7-149786 (1995-06-01), None
patent: 7-242691 (1995-09-01), None
patent: 09-268198 (1997-10-01), None
patent: 11-106395 (1999-04-01), None
patent: 2000-143516 (2000-05-01), None
patent: WO 91/02521 (1991-03-01), None
patent: WO 97/40838 (1997-11-01), None
patent: WO 00/53190 (2000-09-01), None
Peer et al., “Synthesis of an L-Fucose-Derived Cyclic Nitrone and its Conversion to alpha-L-Fucosidase Inhibitors,” Helvetica Chemica Acta, 82(7), 1044-1065 (Jul. 7, 1999).
Sanders et al., “Synthesis of Sulfated Trisaccharide Ligands for the Selectins,” Tetrahedron, 53(48), 16391-16422 (Dec. 1, 1997).
Arasappan et al., “Regiospecific 4, 6-Functionalization of Pyranosides via Dimethylboron Bromide-Mediated Cleavage of Phthalide Orthoesters,” J.American Chemical Society, 117(1), 177-183 (Jan. 11, 1995).
Thiem et al., “Synthesen von Methyl-4-O-(beta-D-curaocsyl)-alpha-D-curamicosid, dem Glycosid der Disaccharideinheit E-F von Flambamycin und Isomeren,” Jusuts Liebig's Annalen der Chemie, 1987(4), 289-295 (Apr. 1987).
Fujimaki et al., “Conversion 1, 6-Anhydromaltose into Pseudodisaccharides Containing Aminocyclitols as Constituent,” Agricultural & Biological Chemistry, 44(9), 2055-2059 (Sep. 1980).
Tulloch et al., “Combination and Positional Distribution of Fatty Acids in Plant Sulfolipids,” Hoppe-Seyler's Zeitschrift Physiol. Chem., 354, 879-889 (Aug. 1973).
Fusetani et al., “Structures of Two Water Soluble Hemolysins Isolated from the Green AlgaUlva pertusa,” Agricultural and Biological Chemistry, 39(10), 2021-2025 (Oct. 1975).
Kitagawa et al., “Sulfoglycolipid from the Sea UrchinAnthocidaris vrassisspinaA. Agassiz,” Chemical & Pharmaceutical Bulletin, 27(8), 1934-1937 (Aug. 1979).
Gustafson et al., “AIDS-Antiviral Sulfolipids From Cyanobacteria (Blue-Green Algae),” J. National Cancer Institute(USA), 81(16), 1255-1258 (Aug. 16, 1989).
Adebodun et al., “Spectroscopic Studies of Lipids and Biological Membranes: Carbon-13 and Proton Magic-Angle Sample-Spinning Nuclear Magnetic Resonance Study of Glycolipid-Water Systems,” Biochemistry, 31(18), 4502-4509 (May 1992).
Gage et al., “Comparison of Sulfoquinovosyl Diacylglycerol from Spinach and the Purple BacteriumRhodobacter sphaeroidesby Fast Atom Bombardment Tandem Mass Spectrometry,” Lipids, 27(8), 632-636 (Aug. 1992).
Morimoto et al., “Studies on Glycolipids. VII. Isolation of Two New Sulfoquinovosyl Diacylglycerols from the Green AlgaChlorella vulgaris,” Chemical & Pharmaceutical Bulletin, 41(9), 1545-1548 (Sep. 1993).
Amarquaye et al., “A New Glycolipid fromByrsonima crassifolia,” Planta Medica, 60(1), 85-86 (Feb. 1994).
Murakami et al., “Enzymatic Transformation of Glyceroglycolipids into sn- 1 and sn- 2 Lysoglyceroglycolipids by Use ofRhizopus arrhizusLipase,” Tetrahedron, 50(7), 1993-2002 (Feb. 14, 1994).
Vishwanath et al., “Interaction of Plant Lipids with 14 kDa Phospholipase A2 Enzymes,” Biochemical Journal, 320(1), 93-99 (Nov. 15, 1996).
Golik et al., “Isolation and Structure Determination of Sulfonoquinovosyl Dipalmitoyl Glyceride, a P-Selectin Receptor Inhibitor from the AlgaDictyochloris fragrans,” Journal of Natural Products, 60(4), 387-389 (Apr. 1997).
Vas{hacek over (S)}nge et al., “A Sulfonoglycolipids from the FernPolypodium decumanumand its Effect on the Platelet Activating-factor Receptor in Human Neutrophils,” Journal of Pharmaceutical Pharmacology, 49(5), 562-566 (May 1997).
Kim et al., “Structural Identification of Glycerolipid Molecular Species Isolated fromCyanobacterium synechocytissp. PCC 6803 Using Fast Atom Bombardment Tandem Mass Spectrometry,” Analytical Biochemistry, 267, 260-270 (1999).
Mizushina et al., “Search and Structural Identification . . . ,” published in A Collection . . . Convention of Natural Organic Compounds, Symposium on the Chemistry of Natural Products, Fukuoka, Japan, Aug. 31, 1998, only pp. 493-498 supplied.
H Nakane & K Ono, “Inhibitor of DNA Polymerase Activity,” Metabolism, 28(12), 1027-1034 (1991).
Pugh et al. (eds.), Stedman's Medical Dictionary, 28the Ed.), Lippincott, Williams and Wilkins, Philadelphia, PA, 2000, only p. 24 supplied.
Byeng, Wha Son; “Glycolipids fromGracilaria verrucosa”, Phytochemistry, vol. 29, No. 1, 1990; pp. 307-309.
Shirahashi Hideaki et al.; “Isolation and Identification of Anti-tumor-Promoting Principles from the Fresh-Water Cyanobacterium Phormidium tenus”, Chem. Pharm. Bull., vol. 41, No. 9, (1993) pp. 1664-1666.
Morimoto, Takashi et al.; “Studies on Glycolipids. VII. Isolation of Two New Sulfoquinovosyl Diacylglycerols from the Green AlgaChlorella vulgaris”, Chem. Pharm. Bull. vol. 41,No. 9, 1993; pp. 1545-1548.
Michael Keusgen et al.; “Sulfoquinovosyl Diacylglycerols from the AlgaHeterosigma carterase”, Lipids, vol. 32,No. 10; 1997; pp. 1101-1102.
Luca Rastrelli et al.; “Glycolipids fromByrsonima crassifolia”; Phytochemistry, vol. 145, No. 4, 1997; pp. 647-650.
Sahara,H. et al.; “In vivo anti-tumour effect of 3′-sulfoquinovosyl-1′-monoacylglyceride isolated from sea urchin (Stronglycoentrotus intermedius) intestine”; British Journal of Cancer, vol. 75,No. 3, 1997; pp. 323-332.
Mizushina, Yoshiyuki et al.; “Studies on Inhibitors of Mammalian DNA Polymerase α and β”,Biochemistry Pharmacology, vol. 55; 1999; pp. 537-541.
Ohta, Keisuke et al.; “Sulfoquinovosyldiacylglycerol,KM043, a New Potent Inhibitor of Eukaryotic DNA Polymeraes and HIV-Reverse Transcriptase Type 1 from Marine Red Alga,Gigartina tenells”; Chem. Pharm. Bull., vol. 46,No. 4; 1998; pp. 684-686.
S. Kashima et al., “A Study of Polymerase Inhibitors of Higher Plants”, Nippon Nogeikagaku Kaisha, vol. 72, Mar. 5, 1998, p. 82.
Yoshiyuki Mizushina, Shonen Yoshida, Akio Matsukage and Kengo Sakaguchi, “The Inhibiting Action of Fatty Acids on DNA Polymerase β”,Biochimica et Biophysica Acta., 1336, (1997), 509-521.
Dana M. Gordon et al., “Synthesis of a Cyanobacterial Sulfolipid: Confirmation of Its Structure, Stereochemistry, and Anti-HIV-1 Activity”,J. Amer. Chem. Soc., 114, 659-663 (1992).
Roy Gigg et al., “Synthesis of 3-O-(6-Deoxy-6-sulpho-α-D-glucopyranosyl)-1,2-di-O-hexadecanoyl-L-glycerol, ‘Sulphoquinovosyl Diglyceride’”,Journal of the Chemical Society Perkin Transaction I, 2490-2493 (1980).
Pham Quang Liem et al., “Struc
Fujita Tatsuya
Masaki Kazuyoshi
Nakayama Kotaro
Ohta Keisuke
Sahara Hiroeki
Crane L. E.
Frishauf Holtz Goodman & Chick P.C.
Jiang S. Anna
Toyo Suisan Kaisha Ltd.
LandOfFree
Method for treating cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treating cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating cancer will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2782234